Press Releases

 
Press Releases
  Date Title View
Aug 1, 2017
Data from Studies in Rare Pediatric Epilepsies and Severe Postpartum Depression Expected in 2nd Half On-track to Initiate Two Additional Phase 2 Trials Later This Year in Status Epilepticus and Moderate Postpartum Depression RADNOR, Pa., Aug. 0...
Jun 29, 2017
RADNOR, Pa., June 29, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicate...
Jun 27, 2017
Program to Evaluate Intravenous and Oral Ganaxolone in Patients with Severe or Moderate Postpartum Depression RADNOR, Pa., June 27, 2017 (GLOBE NEWSWIRE) -- ...
May 1, 2017
RADNOR, Pa., May 01, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the "Company"), a biopharmaceutical com...
Apr 18, 2017
Platform Presentation of Phase 2 Data in Fragile X Syndrome RADNOR, Pa., April 18, 2017 (GLOBE NEWSWIRE) -- ...
Apr 11, 2017
RADNOR, Pa., April 11, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated...
Apr 10, 2017
RADNOR, Pa., April 10, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated...
Mar 15, 2017
RADNOR, Pa., March 15, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated...
Mar 13, 2017
RADNOR, Pa., March 13, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharm...
Feb 14, 2017
Data Published in NeuropharmacologyRADNOR, Pa., Feb. 14, 2017 (GLOBE NEWSWIRE) -- ...
1
...
NextLast
= add release to Briefcase